Literature DB >> 8524862

Evidence for DNA phosphate backbone alkylation and cleavage by pyrrolo[1,2-a]benzimidazoles: small molecules capable of causing base-pair-specific phosphodiester bond hydrolysis.

W G Schulz1, R A Nieman, E B Skibo.   

Abstract

This report presents evidence that a reduced pyrrolo[1,2-a]benzimidazole (PBI) cleaves DNA as a result of phosphate alkylation followed by hydrolysis of the resulting phosphate triester. The base-pair specificity of the phosphate alkylation results from Hoogsteen-type hydrogen bonding of the reduced PBI in the major groove at only A.T and G.C base pairs. Alkylated phosphates were detected by 31P NMR and the cleavage products were detected by 1H NMR and HPLC. Evidence is also presented that a reduced PBI interacts with DNA in the major groove rather than in the minor groove or by intercalation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524862      PMCID: PMC40501          DOI: 10.1073/pnas.92.25.11854

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

Review 1.  Chemical nucleases.

Authors:  D S Sigman
Journal:  Biochemistry       Date:  1990-10-02       Impact factor: 3.162

2.  Design of sequence-specific DNA-binding molecules.

Authors:  P B Dervan
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

3.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  Rational design of substituted tripyrrole peptides that complex with DNA by both selective minor-groove binding and electrostatic interaction with the phosphate backbone.

Authors:  T C Bruice; H Y Mei; G X He; V Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

5.  Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agents.

Authors:  I Islam; E B Skibo; R T Dorr; D S Alberts
Journal:  J Med Chem       Date:  1991-10       Impact factor: 7.446

6.  Pyrrolo[1,2-a]benzimidazole-based aziridinyl quinones. A new class of DNA cleaving agent exhibiting G and A base specificity.

Authors:  E B Skibo; W G Schulz
Journal:  J Med Chem       Date:  1993-10-15       Impact factor: 7.446

7.  31P nuclear magnetic resonance spectra and dissociation constants of lac repressor headpiece.duplex operator complexes: the importance of phosphate backbone flexibility in protein.DNA recognition.

Authors:  M V Botuyan; D A Keire; C Kroen; D G Gorenstein
Journal:  Biochemistry       Date:  1993-07-13       Impact factor: 3.162

8.  Effect of distortions in the phosphate backbone conformation of six related octanucleotide duplexes on CD and 31P NMR spectra.

Authors:  S el antri; P Bittoun; O Mauffret; M Monnot; O Convert; E Lescot; S Fermandjian
Journal:  Biochemistry       Date:  1993-07-20       Impact factor: 3.162

9.  Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymatic reduction by DT-diaphorase.

Authors:  C S Lee; J A Hartley; M D Berardini; J Butler; D Siegel; D Ross; N W Gibson
Journal:  Biochemistry       Date:  1992-03-24       Impact factor: 3.162

10.  DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction.

Authors:  J A Hartley; M Berardini; M Ponti; N W Gibson; A S Thompson; D E Thurston; B M Hoey; J Butler
Journal:  Biochemistry       Date:  1991-12-17       Impact factor: 3.162

View more
  1 in total

1.  Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease.

Authors:  Sanghamitra Bandyopadhyay; Catherine Cahill; Amelie Balleidier; Conan Huang; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.